11:15 AM EST, 11/21/2024 (MT Newswires) -- ImmunityBio ( IBRX ) and nCartes said Thursday they are collaborating to automate and streamline the data fulfillment process for clinical trials.

The collaboration will help expedite the process and make it less expensive for ImmunityBio's ( IBRX ) trial investigators, the companies said.

ImmunityBio ( IBRX ) shares were up about 2% in recent trading.

Price: 4.98, Change: +0.11, Percent Change: +2.15